NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging technology for targeting and treating cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback